Dr. W. Dalton Dietrich, III | Scientific Director, The Miami Project to Cure Paralysis, Miami, Florida Dr. W. Dalton Dietrich is the scientific director of The Miami Project to Cure Paralysis at the University of Miami, Miller School of Medicine. He received his Ph.D. in Anatomy from the Medical College of Virginia in 1979, and completed a postdoctoral fellowship in the Department of Pharmacology at Washington University, St. Louis, MO, in 1981. Immediately following the completion of his fellowship at Washington University, Dr. Dietrich joined the Department of Neurology at the University of Miami, School of Medicine, with a joint appointment in Cell Biology and Anatomy. In 1993, he attained the rank of professor. Dr. Dietrich served as vice-chairman for basic science in the Department of Neurology from 1995 to 1997, prior to accepting the position of scientific director at The Miami Project to Cure Paralysis.
Dr. Dietrich has published three books concerning central nervous system trauma and treatment, written and contributed to 50 book chapters, authored 220 peer-reviewed journal articles, produced 256 abstracts, and written 20 editorial comments and book reviews. He has been a thesis/dissertation advisor for 20 pre-doctoral students and has trained 31 postdoctoral fellows in his laboratory. Currently, Dr. Dietrich serves on study sections for the NIH, the Department of Defense, the Veteran’s Administration, and participates on several editorial boards.
Dr. Dietrich attends University committees, serves on a number of grant committees (the National Institutes of Health, the Department of Defense, the Veterans Administration, the Ralph Wilson Medical Research Foundation, and the Craig H. Nielsen Foundation) and continues to run an active laboratory with his wife, Dr. Helen Bramlett. Together, they conduct cutting-edge research targeting SCI, brain trauma, stroke and cerebral ischemia.
Dr. Myron Ginsberg | Peritz Scheinberg Professor of Neurology, Memorial Medical Center Myron D. Ginsberg, MD, is the Peritz Scheinberg Professor of Neurology, Director of the Cerebral Vascular Disease Research Center, and Co-Director of the Neurotrauma Research Center at the University of Miami/Jackson Memorial Medical Center, Miami Florida. Dr. Ginsberg’s areas of expertise and research interest are around stroke and cerebrovascular disease specifically looking at pharmaceutical agents and strategies that can be utilized to protect the injured brain. He received his medical degree from Harvard Medical School, and served as a resident at Harvard Medical Services, Boston City Hospital as well as the Massachusetts General Hospital, Boston. Moreover Dr. Ginsburg is a well known thought leader in stroke with over 260 publications to his credit.
Dr. Joshua Hare | Director of the Interdisciplinary Stem Cell Institute, Chief of Cardiology and the Louis Lemberg Professor of Medicine, Miller School of Medicine Joshua M. Hare, MD, is the Louis Lemberg Professor of Medicine, Director of the Interdisciplinary Stem Cell Institute, Assistant Dean of Research, and Chief of Cardiology at the Miller School of Medicine, University of Miami, Florida. At Johns Hopkins University he pioneered the use of stem cell therapy to repair damaged hearts. Dr. Hare graduated from the University of Pennsylvania and has a medical degree from Johns Hopkins. He did his residency at Hopkins and fellowships at Hopkins, Harvard University and The Brigham and Women’s Hospital in Boston. Dr. Hare has over 120 publications and 43 invited lectureships over his career thus far.
Dr. Craig Pratt | Professor of Medicine at Weill Cornell Medical College, Director of Research for the Methodist, DeBakey Heart Center and Director of the Coronary Intensive Care Unit at The Methodist Hospital in Houston, Texas Craig M. Pratt, MD, is a Professor of Medicine Weill Medical College of Cornell University, New York, New York, the Vice-Chairman of Research for the Department of Cardiology, Methodist Hospital Research Institute and Director of Research for The Methodist DeBakey Heart Center, The Methodist Hospital, Houston, Texas. Dr. Pratt also acts a consultant to the United States Food and Drug Administration (FDA), and has been the past Chairman of the Cardio-Renal Advisory Board for the FDA. He has been involved with a number of clinical trials investigating drugs aimed at treating cardiac abnormalities and conditions. Dr. Pratt completed his MD at the University of California, Irvine, and undertook residency and fellow training at the University of California, Davis. Dr. Pratt has over 141 publications and been involved with over 37 industry sponsored research projects and clinical trials.
Dr. Samuel Weiss | Professor, Department of Cell Biology & Anatomy/Pharmacology & Therapeutics, Member, Genes and Development Research Group Faculty of Medicine University of Calgary Samuel Weiss, PhD, is a Professor and the Director of the Hotchkiss Brain Institute, and Alberta Heritage Foundation for Medical Research Scientist in the Departments of Cell Biology & Anatomy and Pharmacology & Therapeutics at the University of Calgary, Faculty of Medicine, Calgary, Alberta. He received his BSc in biochemistry from McGill University in Montreal and his PhD in neurobiology from the University of Calgary. Two major discoveries are the hallmarks of Dr. Weiss' research career. In 1985, together with Dr. Fritz Sladeczek, Dr. Weiss discovered the metabotropic glutamate receptor - now a major target for pharmaceutical research and development for neurological disease therapies. In 1992, Dr. Weiss discovered neural stem cells in the brains of adult mammals. In addition to authoring many publications in his field and sitting on numerous national and international peer review committees, Dr. Weiss holds several patents in the neural stem cell field and is a founder of SCT. Dr. Weiss has over 100 publications and 60 invited lectureships in his career to date.
Dr. Weiss was the recent recipient of the 2008 Gairdner Award 'for his seminal discovery of adult neural stem cells in the mammalian brain and its importance in nerve cell regeneration'. Dr. Weiss discovered that the adult brain can produce new cells - adult stem cells that can grow into new brain cells called neurons. The finding raised the prospect of regenerating damaged nerves with stem cells the brain can produce itself. Dr Weiss' stem cell regenerative work is the foundation of SCT's therapeutic approach to stroke, traumatic brain injury and multiple sclerosis.
|